Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01781234
Other study ID # UNM-246
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date August 2013
Est. completion date May 2016

Study information

Verified date December 2018
Source University of New Mexico
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will evaluate safety and efficacy of intranasal insulin in abstinent smokers. Groups' (placebo vs. insulin) cognitive function and stress response will be compared.


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date May 2016
Est. primary completion date May 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- smokers (>10 cig/day) for the past 1 year

- normosmic olfactory function

Exclusion Criteria:

- previous/current use of insulin

- current Diagnostic and Statistical Manual-IV-Revised (DSM-IV-R) Axis I disorder

- current pregnancy (or lactation)

- lifetime history of endocrine disease

- excessive alcohol use (>25 standard units of alcohol/week)

- current use of illicit drugs

- current use of a smoking cessation aid (NRT, Chantix or Wellbutrin), or a psychotropic agent

- local infections, inflammation, structural abnormalities, or other nasal pathology

- current use of any medications administered intranasally, including intranasal steroids

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Intranasal Insulin

Placebo


Locations

Country Name City State
United States UNM College of Pharmacy Albuquerque New Mexico

Sponsors (1)

Lead Sponsor Collaborator
Ajna Hamidovic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Nicotine Craving (Measured by Questionnaire of Smoking Urges) Questionnaire of Smoking Urges; Total Range= 10-70; Higher values represent worse outcome 90 minutes
Primary Episodic Memory California Verbal Learning Task Number of Words Learned Higher Values Mean Better Outcome 90 minutes
Primary Salivary Cortisol 90 minutes
See also
  Status Clinical Trial Phase
Completed NCT02028871 - Intranasal Insulin for Weight Management During Smoking Cessation Phase 2